Multi-residue enantiomeric analysis of pharmaceuticals and their active metabolites in the Guadalquivir River basin (South Spain) by chiral liquid chromatography coupled with tandem mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 18, 2013, Pages 5859-5873

  López Serna, Rebeca ^a   Kasprzyk Hordern, Barbara ^b   Petrović, Mira ^c,d   Barceló, Damià ^a,c  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^b University of Bath   (United Kingdom)

^c CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Chiral pharmaceutical; Enantiomer; LC MS MS; Metabolite; River water; Wastewater

Indexed keywords

CHIRAL LIQUID CHROMATOGRAPHY; CHIRAL PHARMACEUTICALS; DEVELOPMENT AND APPLICATIONS; ENANTIOMERIC COMPOSITION; ENVIRONMENTAL MATRIXES; LC-MS/MS; RIVER WATER; WASTEWATER TREATMENT PLANTS;

ANTIBIOTICS; BIOMOLECULES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; TOXICITY; WASTEWATER; WATERSHEDS;

ENANTIOMERS;

ATENOLOL; CARAZOLOL; DRUG; FLUOXETINE; METOPROLOL; PROPANOLAMINE DERIVATIVE; PROPRANOLOL;

CHEMISTRY; CONFERENCE PAPER; ENVIRONMENTAL MONITORING; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; REPRODUCIBILITY; RIVER; SENSITIVITY AND SPECIFICITY; SPAIN; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; WATER POLLUTANT;

ATENOLOL; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MONITORING; FLUOXETINE; METOPROLOL; PHARMACEUTICAL PREPARATIONS; PROPANOLAMINES; PROPRANOLOL; REPRODUCIBILITY OF RESULTS; RIVERS; SENSITIVITY AND SPECIFICITY; SPAIN; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

PIMEPHALES PROMELAS;

EID: 84879792917     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6900-7     Document Type: Conference Paper

References (24)

1. Lees P, Hunter RP, Reeves PT, Toutain PL (2012) Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. J Vet Pharmacol Ther 35(suppl 1):17-29
2. Kasprzyk-Hordern B (2010) Pharmacologically active compounds in the environment and their chirality. Chem Soc Rev 39(11):4466-4503
3. FDA's policy statement for the development of new stereoisomeric drugs (1992) Chirality 4(5):338-340
4. Agency EM (1994) Investigation of chiral active substances. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500002816.pdf. Accessed 27 March 2011
5. Maier NM, Lindner W (2006) Stereoselective chromatographic methods for drug analysis. In: Francotte E, Lindner W (eds) Chirality in drug research, volume 33. Wiley-VCH, Weinheim
6. Tucker GT (2000) Chiral switches. Lancet 355(9209):1085-1087
7. Sahajwalla C (2004) Regulatory considerations in drug development of stereoisomers. In: Reddy IK, Mehvar R. (eds) Chirality in drug design and development. Dekker, New York
8. Nikolai LN, McClure EL, MacLeod SL, Wong CS (2006) Stereoisomer quantification of the β-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1131(1-2):103-109
9. MacLeod SL, Sudhir P, Wong CS (2007) Stereoisomer analysis of wastewater-derived β-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1170(1-2):23-33
10. Kasprzyk-Hordern B, Kondakal VVR, Baker DR (2010) Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A 1217(27):4575-4586
11. Barclay VKH, Tyrefors NL, Johansson IM, Pettersson CE (2011) Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples. J Chromatogr A 1218(33):5587-5596
12. Kasprzyk-Hordern B, Baker DR (2012) Enantiomeric profiling of chiral drugs in wastewater and receiving waters. Environ Sci Technol 46(3):1681-1691
13. Bagnall JP, Evans SE, Wort MT, Lubben AT, Kasprzyk-Hordern B (2012) Using chiral liquid chromatography quadrupole time-of-flight mass spectrometry for the analysis of pharmaceuticals and illicit drugs in surface and wastewater at the enantiomeric level. J Chromatogr A 1249:115-129
14. Commission Decision (2002/657/EC) of 12 August 2002 Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results O.J.o.t. Commission Decision (2002/657/EC) of 12 August 2002 Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results, Official Journal of the European Communities L221, Brussels, Belgium, pp. 8-36
15. Gros M, Petrović M, Barceló D (2009) Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 81(3):898-912
16. López-Serna R, Petrović M, Barceló D (2011) Development of a fast instrumental method for the analysis of pharmaceuticals in environmental and wastewaters based on ultra high performance liquid chromatography (UHPLC)-tandem mass spectrometry (MS/MS). Chemosphere 85(8):1390-1399
17. López-Serna R, Petrović M, Barceló D (2012) Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). Sci Total Environ 440:280-289
18. Huerta-Fontela M, Galceran MT, Ventura F (2011) Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res 45(3):1432-1442
19. Huerta-Fontela M, Galceran MT, Ventura F (2010) Fast liquid chromatography-quadrupole-linear ion trap mass spectrometry for the analysis of pharmaceuticals and hormones in water resources. J Chromatogr A 1217(25):4212-4222
20. MacLeod SL, Wong CS (2010) Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. Water Res 44(2):533-544
21. Stanley JK, Ramirez AJ, Mottaleb M, Chambliss CK, Brooks BW (2006) Enantiospecific toxicity of the β-blocker propranolol to Daphnia magna and Pimephales promelas. Environ Toxicol Chem 25(7):1780-1786
22. Fono LJ, Sedlak DL (2005) Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ Sci Technol 39(23):9244-9252
23. Barclay VKH, Tyrefors NL, Johansson IM, Pettersson CE (2012) Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A 1227:105-114
24. Stanley JK, Ramirez AJ, Chambliss CK, Brooks BW (2007) Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69(1):9-16